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ABSTRACT 
Background: Type 2 diabetes mellitus results from defects in insulin secretion and/or insulin action or 
both. 
Objectives: The present study was conducted to investigate the hypoglycemic effects of Allium cepa in 
patients with type 2 diabetes mellitus.   
Results: In type 2 diabetic patients (n=21) the administration of crude Allium cepa (100g) markedly reduced 
fasting blood glucose levels by 40 mg/dl 4 hours later, compared to glibenclamide (81 mg/dl). Also Allium 
cepa significantly reduced the induced hyperglycemia (GTT) after ingestion of 75 grams dextrose by 159 
mg/dl in the test subgroup (n=7) of type 2 diabetic patients to a point below that produced in the negative 
control group after 4 hours. 
Conclusion: Crude Allium cepa produced hypoglycemic effects, thus it could be used as a dietary 
supplement in management of diabetes. 
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 INTRODUCTION  
 
Diabetes mellitus is generally classified into 3 classifications: type 1, type 2 and gestational (occurring 
during pregnancy).[1] The chronic hyperglycemia that characterized type 2 diabetes mellitus results from 
both defects in insulin secretion, insulin action or both coupled with resistance to the effects of insulin.[2] 
Some of patients with type 2 diabetes are obese. Indeed, obesity itself, in particular central adiposity, can 
confer some degree of insulin resistance.[3] Although the hyperglycemia symptoms of type 2 diabetes tend 
to develop gradually, patients with chronically elevated blood glucose levels are at increased risk of 
developing micro-and macrovascular complications. Nevertheless, the risk of developing complications 
can be reduced significantly through tight glycemic control.[5] 
In some patients, glycemic control can be achieved with weight reduction, exercise and/or antidiabetic 
agents that promote insulin secretion or lower insulin resistance.[1] Over time, however, the beta-cell 
function of most patients will progressively decline, requiring treatment with combination therapy 
consisting of oral agents and/or exogenous insulin.[4] 
Plants remedies are the mainstay of treatment in underdeveloped regions and may provide valuable clues 
for the development of new oral hypoglycemic agents.[6-8] This has caused an increase in the number of 
experimental and clinical investigations towards the validation of the antidiabetic properties which 
empirically attributed to these remedies. Over 400 traditional plant treatments for diabetes have been 
reported, although a small number of these have received scientific and medical evaluation to assess their 
efficacy and safety.[9] Of these, ginseng species, Momordica Charantia (Bitter Melon), cloves, cinnamon, 
Trigonella foenum graecum (Fenugreek) and Allium cepa (onion) have been used for taste and flavour 
development in food preparations.[10]  
The use of plants especially vegetables by the population as antidiabetic remedies have added interest of 
joining two basic diabetes mellitus control factors: food and medication. [6-8] Plants from the genus Allium, 
particularly onions (Allium cepa) have been consumed for their putative nutritional and health benefits for 
centuries.[11-14]  reports indicated that Allium cepa is rich in sulphides, flavonoids and cysteine 
phytoconstituents which were known to have hypoglycemic, hypocholesterolemic and antibacterial 
potentials,[15-17] and antioxidant activity with beneficial effects on cardiovascular and immune systems, 
inflammatory conditions and cancer prevention.[18-20] The present study was conducted to investigate the 
hypoglycemic effects of Allium cepa in patients with type 2 diabetes mellitus.   
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MATERIAL AND METHODS 
 
Ethical approval  
The ethical approval for this study was obtained from the Ethical Committee/ University of Gezira/ Gezira 
State, Ministry of Health, Wad Medani-Sudan. Consent forms were signed by participants, being interested 
in joining the study completely voluntary bearing in mind that Allium cepa is safe vegetable especially in 
the administered dose. 
Plant material 
Fresh and recently cropped Allium cepa harvested at the optimal maturity was purchased from the local 
market in Wad Medani city, Central Sudan. The fresh onion was cut into small slices to be taken orally by 
type 2 diabetic patients. 
Criteria for selecting patients 
For patients with type 2 diabetes mellitus, the following criteria of selection were considered: age ≤ 50 
years, the duration of diabetes was between 2-5 years. Patients who are taking medicines for other health 
condition, taking vitamins or other supplements, smoking or consuming alcohol and those suffering from 
any of diabetes complications were excluded from the study. 
Type 2 diabetic patients 
Two groups of type 2 diabetic patients were used in this clinical trial to assess the hypoglycaemic effects 
of Allium cepa. Participants of the first group (n=21) of both sexes were subjected to fasting blood glucose 
levels determination and subdivided into three subgroups each consisted of 7 registered patients. Subgroup 
I participants were considered as negative control and received drinking water, while those in subgroup II 
were administered standard positive control treatment of glibenclamide (5mg). Subgroup III received 100g 
of the crude fresh slices of Allium cepa as a test or investigational group.  
 
2.2.6.3 Determination of fasting blood glucose levels in type 2 diabetic patients 
For subgroup I, II and III, as designed and after administration of water or glibenclamide (5mg) and/or the 
fresh slices of Allium cepa (100g), fasting blood glucose levels were determined at 0, 1, 2 and 4 hours, 
using electronic glucometer. (Table 1) 
2.2.6.4 Determination of glucose tolerance tests in type 2 diabetic patients  
 Another group of 21 type 2 diabetic patients were subjected to glucose tolerance tests (GTT). They received 
75 grams dextrose dissolved in water orally. As designed in all subgroups and after administration of water 
or glibenclamide (5mg) and/or fresh slices of Allium cepa (100g), blood glucose levels were determined at 
0, 1, 2 and 4 hours, using electronic glucometer. (Table 2) 
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Statistical Analysis 
All the data were expressed as means ± standard error of means (SEM) and analyzed by analysis of variance 
(ANOVA). Comparisons with the control group were made using One-way ANOVA. Differences were 
considered significant if P < 0.05. 
 
RESULTS AND DISCUSSION 
 
Determination of fasting blood glucose levels in type 2 diabetic patients 
Heterogeneous group of twenty one diabetic individuals of type 2 were used for this study. As shown in 
Table 1 and Figure 1 fasting blood glucose levels in the tested patients with type 2 diabetes were determined. 
The administration of 100g of Allium cepa markedly reduced the fasting blood glucose levels in subgroup 
III diabetic patients (test group) by 40 mg/dl after 4 hours.  
Four hours after oral administration of glibenclamide (5mg) a significant reduction in fasting blood glucose 
levels in subgroup II diabetic patients by about 81 mg/dl was observed, as glibenclamide acts by direct 
induction of insulin release from the pancreatic beta cells, such a significant reduction in glucose levels was 
evident.[21]  
The hypoglycemic activity of Allium cepa has been demonstrated in many clinical studies, presenting that, 
the addition of raw onion to the diet of non-insulin-dependent diabetic subjects decreased the dose of 
antidiabetic medication required to control the disease. [22] The probable mechanism of the hypoglycemic 
action of onion may be mainly due to extra-pancreatic activities on the liver, muscle etc. by enhancing the 
utilization and consumption of glucose peripherally.[23]   
 
 
Table 1: Fasting blood glucose levels in type 2 diabetic patients receiving water (5ml), glibenclamide (5mg) and 
Allium cepa (100g) 
P. value Blood glucose level (mg/dL, mean±S.E.M) Preparations 
4 h 2 h 1 h 0 h 
0.001 148.67±8.67 162.33±19.1 175±22.26 164.33±18.5 Water 
0.003 100.38±6.41 131±7.5 157.5±11.25 181±11.71 Glibenclamide 
0.005 115.5±15.46 150.25± 17.73 165±26.41 155±25.29 Allium cepa 
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Figure 1: Fasting blood glucose levels in type 2 diabetic patients receiving water (5ml), glibenclamide (5mg) and 
Allium cepa (100g) 
 
Determination of glucose tolerance tests (GTT) in type 2 diabetic patients 
Twenty one of type 2 diabetic individuals of both sexes were involved in this part of study. It was noticed 
that, the administration of 75g dextrose caused an increase in the blood glucose levels in all subgroups after 
one hour (hyperglycemic peak). Among the three groups, those who had received Allium cepa demonstrated 
the highest peak compared to others, due to glucogenic effect of Allium cepa [24], nevertheless its 
administration significantly reduced the blood glucose levels in the test subgroup of type 2 diabetic patients 
to a point below that produced in the negative control group after 4 hours (Table 2; Figure 2). The observed 
increase in fasting blood glucose levels during the first hour and after ingestion of Allium cepa which 
attributed to the glucogenic effects of cysteine present in Allium cepa can counteract the common side effect 
(hypoglycemia) of antidiabetic agents currently used if Allium cepa is taken concurrently as food 
supplement. 
The oral administration of glibenclamide (5mg) showed a significant reduction in the induced 
hyperglycemia in the positive control group by 157 mg/dl after 4 hours, compared to water, since it is 
known to act by direct induction of insulin release from the pancreatic beta cells.  
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Table 2: Glucose tolerance test (GTT) in type 2 diabetic patients receiving water (5ml), 
glibenclamide (5mg) and Allium cepa (100g) 
P. 
value 
Glucose level (mg/dL, mean±S.E.M) Preparations 
4 h 2 h 1 h 0 h 
0.004 265±8.67 290±19.1 320±22.26 190±18.55 Water 
0.001 163.2±15.46 203.8±17.73 277±26.41 185.6±25.29 Glibenclamide 
0.002 213±14.11 249± 13.2 372.5±11.25 204.63±11.7 Allium cepa 
 
 
 
 
Figure 2: Glucose tolerance test curves in type 2 diabetic patients receiving water (5ml), glibenclamide (5mg) and 
Allium cepa (100g). 
 
Although the number of study group is small to reach concrete conclusions, it was evident that, 
Allium cepa has hypoglycemic effects that may be beneficial in management of diabetes in 
addition to its other nutritional values.  
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